$SPNC News
Last published 9y ago
- 9y agoSPNCThe Spectranetics' (SPNC) CEO Scott William Drake on Q1 2017 Results - Earnings Call TranscriptEarnings Call Transcripts
- 9y agoATRCPJCSPNCAtriCure Names Two New Members to its Board of DirectorsBusiness WireMASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage management, today announced that Regina Groves and B. Kristine Johnson have been appointed to its Board of Directors. In addition, the company announced that Michael Hooven and Karen Robards, two existing members of the Board of Directors, ...
- 10y agoSPNCThe Spectranetics' (SPNC) CEO Scott Drake on Q3 2016 Results - Earnings Call TranscriptEarnings Call Transcripts
- 10y agoSPNCSpectranetics' (SPNC) CEO Scott Drake on Q1 2016 Results - Earnings Call TranscriptEarnings Call Transcripts
- 10y agoSPNCThe Spectranetics (SPNC) Scott William Drake on Q4 2015 Results - Earnings Call TranscriptEarnings Call Transcripts
- 10y agoSPNCThe Spectranetics (SPNC) Q4 2015 Results - Earnings Call WebcastEarnings Call Transcripts
- 13y agoATRCSPNCDVAAtriCure Appoints Scott Drake to Its Board of DirectorsBusiness WireWEST CHESTER, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (NASDAQ: ATRC), a medical device company and a leader in the development of technologies and solutions for the treatment of atrial fibrillation, or Afib, and systems for the exclusion of the left atrial appendage, today announced that Scott Drake, Chief Executive Officer of the Spectranetics Corporation, has been elected as Director. Donald C. Ha ...